________________________________________________________________________________________________________________________
Celebrating 50 years of innovation
Mikart’ s reputation is built on trust, transparency, and a deep commitment to customer success
With five decades of experience, Mikart has firmly established itself as a reliable contract development and manufacturing organization, offering a comprehensive range of services. The company assists clients in scaling from early-stage concepts through to full commercialization. CEO Michael Kallelis, and Vice President of Marketing, Michelle Hall, share insights into Mikart’ s journey, capabilities, and vision for the future.
“ Founded 50 years ago, Mikart is a mid-sized contract development and manufacturing organization( CDMO) based in the Southeastern US,” says Michael.“ We specialize in the development and manufacturing of small molecule drugs, particularly oral solid doses, as well as nonsterile liquids and suspensions.”
As a full-service CDMO, Mikart supports every stage of the pharmaceutical product lifecycle.“ We offer end-to-end services, from early-phase clinical trial materials to full-scale commercial production,” he explains.“ Our Pharmaceutical Development Services( PDS) team handles everything from formulation chemistry and analytical method development to sourcing raw materials. Once a product receives FDA approval, we seamlessly transition into commercial manufacturing, supporting batch sizes from niche orphan drugs to high-volume generics.”
182